271 results
Page 2 of 14
8-K
EX-99.1
cih6ntij aa
18 Apr 22
ARCA biopharma Establishes Special Committee of the Board of Directors
4:46pm
8-K
EX-99.1
8we066nq952
31 Mar 22
ARCA biopharma Reports Topline Results for ASPEN-COVID-19
4:34pm
424B5
nmfjaj
18 Mar 22
Prospectus supplement for primary offering
4:15pm
8-K
EX-99.1
7tn6rydqi jfe
14 Mar 22
ARCA biopharma Announces 2021 Financial Results and Provides Corporate Update
4:26pm
8-K
EX-99.1
8kk5teuqmuhlgpxcm
2 Dec 21
Topline readout of clinical trial results anticipated in first quarter of 2022
4:16pm
8-K
EX-99.1
v4ygyjhg9d2fmea11xp
2 Nov 21
ARCA biopharma Announces Third Quarter 2021 Financial Results and Provides Corporate Update
4:31pm
8-K
EX-99.1
f8rp3gna
28 Oct 21
ASPEN-COVID-19 Data and Safety Monitoring Committee Recommends Continuing Phase 2b Clinical Trial to Completion Based on Interim Analysis of Efficacy
4:38pm
8-K
EX-99.1
nrzoackw
16 Sep 21
ARCA biopharma Announces Enrollment of First International Patient in Phase 2b Clinical Trial Evaluating rNAPc2 as a Potential Treatment for COVID-19
4:15pm
8-K
EX-99.1
c33naqga 8l
9 Aug 21
ARCA biopharma Announces Submission of PCT Patent Application for the Treatment of Coronavirus Infection and Associated Coagulopathy with rNAPc2
4:16pm
8-K
EX-99.1
llygm akmrjafch
4 Aug 21
ARCA biopharma Announces Second Quarter 2021 Financial Results and Provides Corporate Update
4:31pm
8-K
EX-99.1
n4czlruoce1v36b1
28 Jul 21
Gencaro Atrial Fibrillation Phase 2B Results Selected for Publication in Analysis in full patient cohort shows Gencaro effect compared to standard of care
4:16pm